Malignant pleural effusion: from bench to bedside

被引:173
|
作者
Psallidas, Ioannis [1 ]
Kalomenidis, Ioannis [2 ]
Porcel, Jose M. [3 ]
Robinson, Bruce W. [4 ,5 ]
Stathopoulos, Georgios T. [6 ,7 ,8 ,9 ]
机构
[1] Oxford Univ Hosp Trust, Oxford Ctr Resp Med, Oxford Resp Trials Unit, Oxford, England
[2] Univ Athens, Sch Med, Evangelismos Hosp, Dept Crit Care & Pulm Med 1, Athens, Greece
[3] Arnau de Vilanova Univ Hosp, Biomed Res Inst Lleida, Dept Internal Med, Pleural Med Unit, Lleida, Spain
[4] Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Perth, WA, Australia
[5] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia
[6] Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Achaia, Greece
[7] Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Pneumol Ctr CPC, Munich, Germany
[8] Helmholtz Zentrum Munchen, Munich, Germany
[9] German Ctr Lung Res DZL, Munich, Germany
来源
EUROPEAN RESPIRATORY REVIEW | 2016年 / 25卷 / 140期
基金
欧洲研究理事会;
关键词
MESOTHELIAL CELLS; T-CELLS; DIFFERENTIAL-DIAGNOSIS; LUNG ADENOCARCINOMA; CYTOTOXIC ACTIVITY; TALC PLEURODESIS; MOUSE MODEL; CHEST TUBE; EFFICACY; SURVIVAL;
D O I
10.1183/16000617.0019-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Malignant pleural effusion (MPE) is a common but serious condition that is related with poor quality of life, morbidity and mortality. Its incidence and associated healthcare costs are rising and its management remains palliative, with median survival ranging from 3 to 12 months. During the last decade there has been significant progress in unravelling the pathophysiology of MPE, as well as its diagnostics, imaging, and management. Nowadays, formerly bed-ridden patients are genotyped, phenotyped, and treated on an ambulatory basis. This article attempts to provide a comprehensive overview of current advances in MPE from bench to bedside. In addition, it highlights unanswered questions in current clinical practice and suggests future directions for basic and clinical research in the field.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 50 条
  • [21] Fibrin turnover and pleural organization: bench to bedside
    Komissarov, Andrey A.
    Rahman, Najib
    Lee, Y. C. Gary
    Florova, Galina
    Shetty, Sreerama
    Idell, Richard
    Ikebe, Mitsuo
    Das, Kumuda
    Tucker, Torry A.
    Idell, Steven
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 314 (05) : L757 - L768
  • [22] Malignant Pleural Effusion in Malignant Pleural Mesothelioma An Innocent Bystander?
    Muruganandan, Sanjeevan
    Duong, Victor
    CHEST, 2021, 160 (05) : 1602 - 1603
  • [23] Rare malignant pleural effusion from metastatic lung and pleural melanoma
    Ng, Boon Hau
    Liew, Kok Leong
    Low, Hsueh Jing
    Abeed, Nik Nuratiqah Nik
    Jailaini, Mas Fazlin Mohamad
    Azmel, Azat Azrai
    Hamid, Mohamed Faisal Abdul
    Ban, Yu-Lin Andrea
    RESPIROLOGY, 2023, 28 : 311 - 311
  • [24] Management of malignant pleural effusion
    Taubert, J
    NURSING CLINICS OF NORTH AMERICA, 2001, 36 (04) : 665 - +
  • [25] Malignant Pleural Effusion Management
    Ferreiro, Lucia
    Suarez-Antelo, Juan
    Valdes, Luis
    ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 (01): : 7 - 8
  • [26] AN UNCOMMON MALIGNANT PLEURAL EFFUSION
    Sanchez, Israel Acosta
    Macias, Kathlyn Camargo
    Madanieh, Abed
    Orabi, Chirin
    Otoya, Jorge
    CHEST, 2019, 156 (04) : 1468A - 1468A
  • [27] Sonography of malignant pleural effusion
    C. Görg
    I. Restrepo
    W. B. Schwerk
    European Radiology, 1997, 7 : 1195 - 1198
  • [28] MANAGEMENT OF MALIGNANT PLEURAL EFFUSION
    GREENWALD, DW
    PHILLIPS, C
    BENNETT, JM
    JOURNAL OF SURGICAL ONCOLOGY, 1978, 10 (04) : 361 - 368
  • [29] Management of malignant pleural effusion
    Tattersall, M
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (03): : 394 - 396
  • [30] TRANSUDATIVE MALIGNANT PLEURAL EFFUSION
    ENG, P
    GOLISH, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A92 - A92